Ameren Q3 GAAP EPS $2.35 vs. $1.70; 2025 EPS guidance raised to $5.08-$5.28
Ameren reported third quarter 2025 GAAP net income of $640 million, or $2.35 per diluted share, up from $456 million, or $1.70, a year earlier. Adjusted diluted EPS was $2.17, compared with $1.87. The company raised its 2025 GAAP EPS guidance to $5.08 to $5.28 and set 2026 diluted EPS guidance at $5.25 to $5.45, though the quarter included a $48 million tax benefit that the company excluded from adjusted results.
Key points
- Q3 2025 GAAP diluted EPS was $2.35 vs. $1.70 in Q3 2024; adjusted diluted EPS was $2.17 vs. $1.87.
- Q3 2025 included a $48 million ($0.18 per share) tax benefit from a FERC order on net operating loss carryforwards, excluded from adjusted earnings.
- 2025 GAAP EPS guidance raised to $5.08 to $5.28 and adjusted EPS guidance to $4.90 to $5.10, both up from the original $4.85 to $5.05 range.
- 2026 diluted EPS guidance set at $5.25 to $5.45; analyst call scheduled for 9 a.m. Central Time on November 6, 2025.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:10 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.